SeaStar Medical Holding Corporation (ICU)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.54M
Last updated: Nov 17, 2026 at 4:43 PM ET
SeaStar Medical Holding Corporation (ICU) Statistics
SeaStar Medical Holding (ICU) has a market cap of $4.54M and an enterprise value of $548.20K. It kept -678.24% of revenue as net income over the last 12 months. Revenue grew 145.74% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 87.92% below the market cap, as cash exceeds debt.
| Market Cap | $4.54M |
|---|---|
| Enterprise Value | $548.20K |
| Latest price (Nov 17, 2026) | $0.78 |
Key Dates
The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 11, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.6x and 7.3x.
| P/S Ratio | 1.6x |
|---|---|
| Forward P/S | 2.3x |
| P/B Ratio | 7.3x |
Price Statistics
The stock is down 79.45% over 52 weeks and trades 72.54% below its 50-day average.
| Beta (1Y) | 1.36 |
|---|---|
| 52-Week Change | -79.45% |
| 1-Month Change | -74.89% |
| 3-Month Change | -76.12% |
| 6-Month Change | -79.92% |
| Total Return (1Y) | -79.45% |
| Total Return (3Y CAGR) | -82.15% |
| Max Drawdown (1Y) | -84.63% |
| Max Drawdown (3Y) | -99.78% |
| Sharpe Ratio (1Y) | -1.19 |
| Correlation with SPY (1Y) | 0.15 |
| 50-Day Average | $2.84 |
| 200-Day Average | $3.28 |
| 52-Week Range | $0.79 to $5.38 |
| RSI (14 Days) | 20.7 |
| Average Volume (20 Days) | 290.78K |
Financial Position
Current assets cover 1.03x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 1.03x |
|---|---|
| Quick Ratio | 1.02x |
| Debt / Equity | 0.00x |
| Interest Coverage | -555.30x |
Returns and Efficiency
Return on equity is -3130.92% and return on assets is -276.53% over the last 12 months.
| Return on Equity (ROE) | -3130.92% |
|---|---|
| Return on Assets (ROA) | -276.53% |
| ROIC (5Y Average) | 503.05% |
| Asset Turnover | 0.21x |
| Inventory Turnover | 2.62x |
| Receivables Turnover | 11.22x |
| Cash Conversion Cycle | -2357 days |
Scores
ICU has an Altman Z-Score of -51.56, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -51.56 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $2.17M over the last 12 months.
| Revenue | $2.17M |
|---|---|
| Revenue Growth (YoY) | +145.74% |
| Gross Profit | $2.00M |
| Operating Income | -$14.99M |
| Pretax Income | -$14.68M |
| Net Income | -$14.68M |
| Reported EPS (TTM) | -$3.64 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 8.83% of the $5.31M in total assets.
| Cash and Equivalents | $3.99M |
|---|---|
| Total Debt | $0 |
| Net Cash | $3.99M |
| Net Cash Per Share | $0.91 |
| Working Capital | $126.00K |
| Shareholder Equity | $469.00K |
| Book Value Per Share | $0.11 |
| Total Assets | $5.31M |
| Total Liabilities | $4.84M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$13.22M |
|---|---|
| FCF Per Share | -$2.49 |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -692.52%.
| Gross Margin | 92.61% |
|---|---|
| Operating Margin | -692.52% |
| Pretax Margin | -678.11% |
| Net Margin | -678.24% |
Dividends and Yields
ICU does not pay a dividend.
| Buyback Yield | -101.11% |
|---|---|
| Shareholder Yield | -101.11% |
Stock Splits
The last split was a 1-for-10 reverse split on Jan 5, 2026.
| Last Split Date | Jan 5, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Analyst Forecast
Consensus estimates put revenue growth at 55.92% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +55.92% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About ICU
What is ICU's market cap?
SeaStar Medical Holding has a market cap of $4.54M. Its enterprise value, which adds debt and subtracts cash, is $548.20K.
How many shares of ICU are outstanding?
SeaStar Medical Holding has 4.39M shares outstanding.
Does ICU pay a dividend?
No. SeaStar Medical Holding does not pay a dividend.
How much debt does ICU have?
SeaStar Medical Holding has $0 of total debt and $3.99M of cash and equivalents, a net cash position of $3.99M.
ICU pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors